PEER-REVIEWED PUBLICATIONS
Clinical Futures investigators are international experts in their clinical research related fields and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here, you can access Clinical Futures journal article abstracts by author, title, or year.
2020
Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group
J Clin Oncol, 2020
Todd Cooper, Michael Absalon, Todd Alonzo, Robert Gerbing, Kasey Leger, Betsy Hirsch, Jessica Pollard, Bassem Razzouk, Richard Aplenc, Anders Kolb
J Clin Oncol, 2020
Todd Cooper, Michael Absalon, Todd Alonzo, Robert Gerbing, Kasey Leger, Betsy Hirsch, Jessica Pollard, Bassem Razzouk, Richard Aplenc, Anders Kolb
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group
Blood Adv, 2020
Karen Chisholm, Amy Heerema-McKenney, John Choi, Jenny Smith, Rhonda Ries, Betsy Hirsch, Susana Raimondi, Todd Alonzo, Yi-Cheng Wang, Richard Aplenc, Lillian Sung, Alan Gamis, Soheil Meshinchi, Samir Kahwash
Blood Adv, 2020
Karen Chisholm, Amy Heerema-McKenney, John Choi, Jenny Smith, Rhonda Ries, Betsy Hirsch, Susana Raimondi, Todd Alonzo, Yi-Cheng Wang, Richard Aplenc, Lillian Sung, Alan Gamis, Soheil Meshinchi, Samir Kahwash
2019
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial
Blood Cancer J, 2019
Roya Rafiee, Lata Chauhan, Todd Alonzo, Yi-Cheng Wang, Ahlam Elmasry, Michael Loken, Jessica Pollard, Richard Aplenc, Susana Raimondi, Betsy Hirsch, Irwin Bernstein, Alan Gamis, Soheil Meshinchi, Jatinder Lamba
Blood Cancer J, 2019
Roya Rafiee, Lata Chauhan, Todd Alonzo, Yi-Cheng Wang, Ahlam Elmasry, Michael Loken, Jessica Pollard, Richard Aplenc, Susana Raimondi, Betsy Hirsch, Irwin Bernstein, Alan Gamis, Soheil Meshinchi, Jatinder Lamba
Functional Properties of KIT Mutations are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
Clin Cancer Res, 2019
Katherine Tarlock, Todd Alonzo, Yi-Cheng Wang, Robert Gerbing, Rhonda Ries, Tiffany Hylkema, Jason Joaquin, Leela Sarukkai, Susana Raimondi, Betsy Hirsch, Lillian Sung, Richard Aplenc, Irwin Bernstein, Alan Gamis, Soheil Meshinchi, Jessica Pollard, Michael Loken, Laura Pardo
Clin Cancer Res, 2019
Katherine Tarlock, Todd Alonzo, Yi-Cheng Wang, Robert Gerbing, Rhonda Ries, Tiffany Hylkema, Jason Joaquin, Leela Sarukkai, Susana Raimondi, Betsy Hirsch, Lillian Sung, Richard Aplenc, Irwin Bernstein, Alan Gamis, Soheil Meshinchi, Jessica Pollard, Michael Loken, Laura Pardo
2017
Disease Characteristics and Prognostic Implications of Cell Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Clin Cancer Res, 2017
Katherine Tarlock, Todd Alonzo, Michael Loken, Robert Gerbing, Rhonda Ries, Richard Aplenc, Lillian Sung, Susana Raimondi, Betsy Hirsch, Samir Kahwash, Amy McKenney, Anders Kolb, Alan Gamis, Soheil Meshinchi
Clin Cancer Res, 2017
Katherine Tarlock, Todd Alonzo, Michael Loken, Robert Gerbing, Rhonda Ries, Richard Aplenc, Lillian Sung, Susana Raimondi, Betsy Hirsch, Samir Kahwash, Amy McKenney, Anders Kolb, Alan Gamis, Soheil Meshinchi
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
J Clin Oncol, 2017
Jatinder Lamba, Lata Chauhan, Miyoung Shin, Michael Loken, Jessica Pollard, Yi-Cheng Wang, Rhonda Ries, Richard Aplenc, Betsy Hirsch, Susana Raimondi, Roland Walter, Irwin Bernstein, Alan Gamis, Todd Alonzo, Soheil Meshinchi
J Clin Oncol, 2017
Jatinder Lamba, Lata Chauhan, Miyoung Shin, Michael Loken, Jessica Pollard, Yi-Cheng Wang, Rhonda Ries, Richard Aplenc, Betsy Hirsch, Susana Raimondi, Roland Walter, Irwin Bernstein, Alan Gamis, Todd Alonzo, Soheil Meshinchi
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials, AAML03P1 and AAML0531
Blood, 2017
Erin Guest, Richard Aplenc, Lillian Sung, Susana Raimondi, Betsy Hirsch, Todd Alonzo, Robert Gerbing, Yi-Cheng Wang, Samir Kahwash, Amy Heerema-McKenney, Soheil Meshinchi, Alan Gamis
Blood, 2017
Erin Guest, Richard Aplenc, Lillian Sung, Susana Raimondi, Betsy Hirsch, Todd Alonzo, Robert Gerbing, Yi-Cheng Wang, Samir Kahwash, Amy Heerema-McKenney, Soheil Meshinchi, Alan Gamis
2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
J Clin Oncol, 2016
Jessica Pollard, Michael Loken, Robert Gerbing, Susana Raimondi, Betsy Hirsch, Richard Aplenc, Irwin Bernstein, Alan Gamis, Todd Alonzo, Soheil Meshinchi
J Clin Oncol, 2016
Jessica Pollard, Michael Loken, Robert Gerbing, Susana Raimondi, Betsy Hirsch, Richard Aplenc, Irwin Bernstein, Alan Gamis, Todd Alonzo, Soheil Meshinchi
2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Clin Cancer Res, 2015
Katherine Tarlock, Todd Alonzo, Robert Gerbing, Susana Raimondi, Betsy Hirsch, Lillian Sung, Jessica Pollard, Richard Aplenc, Michael Loken, Alan Gamis, Soheil Meshinchi
Clin Cancer Res, 2015
Katherine Tarlock, Todd Alonzo, Robert Gerbing, Susana Raimondi, Betsy Hirsch, Lillian Sung, Jessica Pollard, Richard Aplenc, Michael Loken, Alan Gamis, Soheil Meshinchi
Filter by Year
Contact Information
2716 South Street, 10th and 11th Floors Philadelphia, PA 19146